Brentano Fabia, Schorr Olivier, Gay Renate E, Gay Steffen, Kyburz Diego
University Hospital, Zurich, Switzerland.
Arthritis Rheum. 2005 Sep;52(9):2656-65. doi: 10.1002/art.21273.
OBJECTIVE: To assess the expression of Toll-like receptor 3 (TLR-3) protein in synovial tissues and cultured synovial fibroblasts obtained from patients with rheumatoid arthritis (RA) and osteoarthritis (OA) and to investigate the consequences of stimulation of cultured synovial fibroblasts with TLR-3 ligands. METHODS: TLR-3 expression in synovial tissues was determined by immunohistochemistry and immunofluorescence, and expression in cultured RA synovial fibroblasts (RASFs) was determined by fluorescence-activated cell sorting and real-time polymerase chain reaction techniques. TLR-3 signaling was assessed by incubating RASFs with poly(I-C), lipopolysaccharide, palmitoyl-3-cysteine-serine-lysine-4, or necrotic synovial fluid cells from RA patients in the presence or absence of hydroxychloroquine or Benzonase. Subsequent determination of interferon-beta (IFNbeta), CXCL10, CCL5, and interleukin-6 (IL-6) protein production in the culture supernatants was performed by enzyme-linked immunosorbent assays. RESULTS: TLR-3 protein expression was found to be higher in RA synovial tissues than in OA synovial tissues. TLR-3 expression was localized predominantly in the synovial lining, with a majority of the TLR-3-expressing cells coexpressing fibroblast markers. Stimulation of cultured RASFs with the TLR-3 ligand poly(I-C) resulted in the production of high levels of IFNbeta, CXCL10, CCL5, and IL-6 protein. Similarly, coincubation of RASFs with necrotic synovial fluid cells from patients with RA resulted in up-regulation of these cytokines and chemokines in a TLR-3-dependent manner. CONCLUSION: Our findings demonstrate the expression of TLR-3 in RA synovial tissue and the activation of RASFs in vitro by the TLR-3 ligand poly(I-C) as well as by necrotic RA synovial fluid cells, and indicate that RNA released from necrotic cells might act as an endogenous TLR-3 ligand for the stimulation of proinflammatory gene expression in RASFs.
目的:评估类风湿关节炎(RA)和骨关节炎(OA)患者滑膜组织及培养的滑膜成纤维细胞中Toll样受体3(TLR-3)蛋白的表达,并研究用TLR-3配体刺激培养的滑膜成纤维细胞的后果。 方法:通过免疫组织化学和免疫荧光法测定滑膜组织中TLR-3的表达,通过荧光激活细胞分选和实时聚合酶链反应技术测定培养的RA滑膜成纤维细胞(RASF)中的表达。通过在有或没有羟氯喹或核酸酶的情况下,将RASF与聚肌胞苷酸(poly(I-C))、脂多糖、棕榈酰-3-半胱氨酸-丝氨酸-赖氨酸-4或RA患者的坏死滑膜液细胞一起孵育来评估TLR-3信号传导。随后通过酶联免疫吸附测定法测定培养上清液中干扰素-β(IFNβ)、CXCL10、CCL5和白细胞介素-6(IL-6)蛋白的产生。 结果:发现RA滑膜组织中TLR-3蛋白表达高于OA滑膜组织。TLR-3表达主要定位于滑膜衬里,大多数表达TLR-3的细胞共表达成纤维细胞标志物。用TLR-3配体聚肌胞苷酸刺激培养的RASF导致高水平的IFNβ、CXCL10、CCL5和IL-6蛋白产生。同样,将RASF与RA患者的坏死滑膜液细胞共同孵育导致这些细胞因子和趋化因子以TLR-3依赖性方式上调。 结论:我们的研究结果证明了RA滑膜组织中TLR-3的表达以及TLR-3配体聚肌胞苷酸和坏死RA滑膜液细胞在体外对RASF的激活,并表明坏死细胞释放的RNA可能作为内源性TLR-3配体刺激RASF中促炎基因的表达。
Medicina (Kaunas). 2024-11-5
Front Immunol. 2024
Inflammation. 2023-6
Viruses. 2022-11-3
JCI Insight. 2022-7-8